Ownership history in MAVERICK CAPITAL LTD · 8 quarters on record
This page tracks every 13F SEC filing in which MAVERICK CAPITAL LTD reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,212,701 | -44,309 | -2.0% | 0.64% | $47.8M | $21.58 |
| 2025 Q2 | ADDED | 2,257,010 | +195,736 | +9.5% | 0.47% | $31.6M | $13.98 |
| 2025 Q1 | ADDED | 2,061,274 | +7,368 | +0.4% | 0.49% | $27.8M | $13.48 |
| 2024 Q4 | ADDED | 2,053,906 | +56,753 | +2.8% | 0.71% | $39.4M | $19.17 |
| 2024 Q3 | REDUCED | 1,997,153 | -1,310,792 | -39.6% | 0.89% | $45.4M | $22.75 |
| 2024 Q2 | ADDED | 3,307,945 | +615,531 | +22.9% | 0.82% | $43.0M | $13.01 |
| 2024 Q1 | ADDED | 2,692,414 | +366,573 | +15.8% | 0.89% | $47.1M | $17.51 |
| 2023 Q4 | INITIATED | 2,325,841 | — | — | 1.02% | $50.7M | — |
As of 2025 Q4 — sorted by position size